Videos

Educating Patients With Breast Cancer on Aspects Outside of Treatment

August 27th 2021

CURE spoke with Maimah Karmo, founder and CEO of the Tigerlily Foundation, about aspects outside of breast cancer treatment, like financial toxicity, psychosocial effects and more.

Addressing Disparities in Breast Cancer

August 27th 2021

CURE spoke with Maimah Karmo, founder and CEO of the Tigerlily Foundation, about disparities in breast cancer care, and how they are being addressed.

Joining a Breast Cancer Clinical Trial

August 27th 2021

On behalf of TigerLilly Foundation, CURE spoke with Dr. Andrea Phillips about clinical trials in breast cancer.

Understanding HER2-Positive Breast Cancer: Diagnosis, Testing and More

August 27th 2021

On behalf of TigerLilly Foundation, CURE spoke with Dr. Angelique Richardson, from UCSD Health, about HER2-positive breast cancer.

Confirming a Diagnosis of Multiple Myeloma

August 27th 2021

Marcella shares how she met her diagnosis of multiple myeloma as Kenneth Shain, M.D., Ph.D., considers her experience in relation to other patients with multiple myeloma.

Educated Patient® Webinar: Individualized Treatment for Small Cell Lung Cancer

August 26th 2021

View the full CURE® Educated Patient® Webinar: Individualized Treatment for Small Cell Lung Cancer on demand.

Educated Patient® Webinar: Stomach Cancer 101 Series: Part II – Treatment

August 23rd 2021

View the full CURE® Educated Patient® Webinar: Stomach Cancer 101 Series: Part II - Treatment on demand.

Drug Combo Provides Clinical Benefit With Fewer Side Effects in B-Cell Lymphoma

August 20th 2021

Combining PI3 kinase inhibitors with BTK inhibitors can mitigate side effects traditionally seen with PI3 kinase inhibitors, according to recent research.

Advice for Future Patients and Caregivers in TNBC

August 17th 2021

Latasha Jordan and Aditya Bardia, M.D., MPH, share advice for patients and caregivers on the importance of a positive outlook and attitude when living with triple-negative breast cancer.

Social Support Systems for Patients With TNBC

August 17th 2021

A triple-negative breast cancer (TNBC) survivor, Latasha Jordan, considers the positive impact her support network has had on her treatment; and Aditya Bardia, M.D., MPH, emphasizes the importance of social support systems for patients with TNBC.

Safety and Efficacy of Sacituzumab Govitecan

August 17th 2021

Latasha Jordan discusses her experience in a clinical trial with sacituzumab govitecan and comments on the side effects she experienced as well as the overall impact on her quality of life.

The ASCENT 3 Trial of Sacituzumab Govitecan for TNBC

August 17th 2021

An expert oncologist highlights the importance of discussing clinical trial options with patients and comments on the recent FDA approval of sacituzumab govitecan in triple-negative breast cancer based on the ASCENT 3 trial.

Considerations for Referral After Progression of TNBC

August 17th 2021

A patient with triple-negative breast cancer, Latasha Jordan, reflects on the mental and emotional challenges she faced when she learned of her disease progression and shares her positive experience with physician referral thereafter.

Active Surveillance for Disease Progression in TNBC

August 17th 2021

A leader in breast oncology and a triple-negative breast cancer survivor discuss the role of active surveillance for post-surgical disease progression and emphasize the importance of support from health care providers after recurrence.

Surgical Options for Triple-Negative Breast Cancer

August 17th 2021

Aditya Bardia, M.D., MPH, and triple-negative breast cancer survivor, Latasha Jordan, discuss the importance of shared decision-making when considering mastectomy or lumpectomy and radiation for triple-negative breast cancer.

Neoadjuvant Chemotherapy for TNBC

August 17th 2021

Latasha Jordan discusses her experience with neoadjuvant chemotherapy, and an expert in the management of breast cancer, Aditya Bardia, M.D., MPH, reviews common side events associated with systemic treatment.

Longest Living Person to Receive Gleevec for Leukemia Shares Advice

August 16th 2021

Mel Mann, the longest living person who participated in the clinical trial for Gleevec – which was approved by the FDA just over 20 years ago – shares what he would tell his younger self.

How a Cancer Survivor Trained for ‘American Ninja Warrior’ During Treatment

August 16th 2021

Liposarcoma survivor Arianne Missimer discusses the training process for ‘American Ninja Warrior’ and how she felt the day of competition.

Educated Patient® Lung Cancer Summit Basics of Lung Cancer Session: August 14, 2021

August 14th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.

Educated Patient® Lung Cancer Summit Targeted Treatment Session: August 14, 2021

August 14th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.

Educated Patient® Lung Cancer Summit Looking Ahead Session: August 14, 2021

August 14th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.

Cancer Care in LGBTQ Patients: Where We Are and What We Need

August 9th 2021

More people are aware of the disparities LGBTQ patients face, but prohibitive legislature could be moving the needle backward when it comes to equality in care.

Survivor Turns Negative Thoughts Into Laughable Moments During Cancer Treatment

August 6th 2021

A survivor shares how she chose to approach her mindset during cancer treatments to keep herself from spiraling.

Educated Patient® Leukemia Summit: July 31, 2021

August 3rd 2021

View the full CURE Educated Patient Leukemia Summit on demand.

Coping With a Leg Amputation and Segregation During Cancer Treatment at Age 9

August 2nd 2021

A survivor of osteosarcoma who underwent treatment in the 1960s in a segregated hospital ward, shares how he was able to find strength during that time.

Understanding MPN Symptom Management

July 30th 2021

CURE spoke with Dr. Rajiit Rampal, on behalf of the MPN Research Foundation, about MPN symptoms and their management.

Helping Patients With MPNs to Elevate Their Voice

July 30th 2021

CURE spoke with Brandon Goetzman, board member from the MPN Research Foundation, on elevating the patient’s voice when it comes to their care for myeloproliferative neoplasms.

Highlighting the Need for Clinical Trial Education in MPNs

July 30th 2021

CURE spoke with Dr. Gabriela Hobbs, on behalf of the MPN Research Foundation, about the need for clinical trial education for patients with myeloproliferative neoplasms.

Educating Patients on MPN Disease Progression

July 30th 2021

CURE spoke with Dr. Rajiit Rampal, on behalf of the MPN Research Foundation, about disease progression in myeloproliferative neoplasms.

Discussing MPN Treatment Options

July 30th 2021

CURE spoke with Dr. Gabriela Hobbs, on behalf of the MPN Research Foundation, about currently available treatment options, as well as those under clinical investigation, for patients with myeloproliferative neoplasms.